Disparities in the surgical staging of high-grade endometrial cancer in the United States.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28116108)

Published in Gynecol Oncol Res Pract on January 19, 2017

Authors

Jonathan R Foote1, Stephanie Gaillard1, Gloria Broadwater2, Julie A Sosa3,4, Brittany Davidson1, Mohamed A Adam3, Angeles Alvarez Secord1, Monica B Jones1, Junzo Chino5, Laura J Havrilesky1

Author Affiliations

1: Division of Gynecologic Oncology, Duke University Medical Center, 2301 Erwin Rd, Durham, NC 27710 USA.
2: Biostatistics, Duke Cancer Institute, Duke University, 2301 Erwin Rd, Durham, NC 27710 USA.
3: Department of Surgery, Duke University Medical Center, 2301 Erwin Rd, Durham, NC 27710 USA.
4: Duke Clinical Research Institute, Durham, USA.
5: Division of Radiation Oncology, Duke University Medical Center, 2301 Erwin Rd, Durham, NC 27710 USA.

Articles cited by this

Cancer statistics, 2016. CA Cancer J Clin (2016) 32.95

Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet (2010) 5.05

Uterine papillary serous carcinoma: patterns of metastatic spread. Gynecol Oncol (1994) 2.93

Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer (2006) 2.67

Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol (1995) 2.17

The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm. Gynecol Oncol (2010) 1.61

Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review. Gynecol Oncol (2009) 1.49

Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival. Am J Public Health (2004) 1.42

Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer. Gynecol Oncol (2000) 1.30

The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma. Gynecol Oncol (2000) 1.27

Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer? Int J Radiat Oncol Biol Phys (2002) 1.21

Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women. Gynecol Oncol (1997) 1.18

Effect of surgical volume on morbidity and mortality of abdominal hysterectomy for endometrial cancer. Obstet Gynecol (2011) 1.14

Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern. Cancer (1996) 1.11

Differences in treatment and outcome between African-American and white women with endometrial cancer. J Clin Oncol (2003) 1.10

The National Cancer Data Base report on endometrial carcinoma in African-American women. Cancer (1998) 1.08

Resection of lymph node metastases influences survival in stage IIIC endometrial cancer. Gynecol Oncol (2005) 1.02

Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States. Gynecol Oncol (2013) 1.02

Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status. Gynecol Oncol (2014) 1.02

Endometrial cancer: stage at diagnosis and associated factors in black and white patients. Am J Obstet Gynecol (1995) 1.00

Influence of surgical volume on outcome for laparoscopic hysterectomy for endometrial cancer. Ann Surg Oncol (2011) 0.96

Management of women with clear cell endometrial cancer: a Society of Gynecologic Oncology (SGO) review. Gynecol Oncol (2009) 0.95

Comparing national cancer registries: The National Cancer Data Base (NCDB) and the Surveillance, Epidemiology, and End Results (SEER) program. J Surg Oncol (2014) 0.90

Endometrial cancer surgery in Arizona: a statewide analysis of access to care. Gynecol Oncol (2011) 0.86

Racial disparities in treatment of high-grade endometrial cancer in the Medicare population. Obstet Gynecol (2015) 0.82

Race and clinical outcome in endometrial carcinoma. Obstet Gynecol (1999) 0.81

Effects of surgical volumes on the survival of endometrial carcinoma. Gynecol Oncol (2015) 0.77